摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Ethyl-1-azabicyclo[2.2.2]octan-1-ium | 15302-97-3

中文名称
——
中文别名
——
英文名称
1-Ethyl-1-azabicyclo[2.2.2]octan-1-ium
英文别名
1-ethyl-1-azoniabicyclo[2.2.2]octane
1-Ethyl-1-azabicyclo[2.2.2]octan-1-ium化学式
CAS
15302-97-3
化学式
C9H18N+
mdl
——
分子量
140.25
InChiKey
YMOBRTJUJVJAHJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

文献信息

  • Bicyclic compound, production and use thereof
    申请人:Shiraishi Mitsuru
    公开号:US20080161287A1
    公开(公告)日:2008-07-03
    The present invention provides a new cyclic compound having a CCR antagonist activity, especially a CCR5 antagonist activity, and the use thereof. The compound of the present invention is represented by the formula: wherein, R 1 is a 5- to 6-membered ring group which may be substituted; X 1 is a bond or the like; ring A is a 5- to 6-membered ring group which may be substituted; ring B is a 8- to 10-membered ring group which may be substituted; X 2 is a bivalent group of 1 to 4 atoms; Z 1 is a bivalent cyclic ring group or the like; Z 2 is a bond or the like; and R 2 is an amino group, a nitrogen-containing heterocyclic group which may be substituted or the like, or a salt thereof.
    本发明提供了一种具有CCR拮抗剂活性的新环状化合物,特别是CCR5拮抗剂活性,以及其用途。本发明的化合物由以下公式表示:其中,R1是一个5到6个成员的环状基团,可以被取代;X1是一个键或类似物;环A是一个5到6个成员的环状基团,可以被取代;环B是一个8到10个成员的环状基团,可以被取代;X2是1到4个原子的双价基团;Z1是一个双价的环状基团或类似物;Z2是一个键或类似物;R2是基、含氮杂环基团,可以被取代或类似物的盐。
  • Method for manufacturing stabilized polyacetal resin, stabilized polyacetal resin, stabilized polyacetal resin composition, and molded article of stabilized polyacetal resin
    申请人:Polyplastics Co., Ltd.
    公开号:EP1867667A1
    公开(公告)日:2007-12-19
    The present invention provides an agent to decompose unstable terminal group, which is effective in a small adding amount, which sufficiently decreases the quantity of residual unstable terminal group, and which generates very little limitation on the treatment method, the apparatus, and the use amount of the agent. Specifically, it provides a method for manufacturing stabilized polyacetal resin having the step of applying heat treatment to a polyacetal resin having an unstable terminal group in the presence of an agent to decompose the unstable terminal group, which agent is composed of a heterocyclic quaternary ammonium salt, thus decreasing the quantity of the unstable terminal group.
    本发明提供了一种分解不稳定末端基团的药剂,其添加量小,效果好,能充分减少残留的不稳定末端基团的数量,并且对处理方法、装置和药剂的使用量限制很小。具体地说,它提供了一种制造稳定聚缩醛树脂的方法,该方法的步骤是:在有药剂存在的情况下,对具有不稳定末端基团的聚缩醛树脂进行热处理,以分解不稳定末端基团,该药剂由杂环季盐组成,从而减少不稳定末端基团的数量。
  • TRANSDERMAL DELIVERY SYSTEMS OF BETA-LACTAM ANTIBIOTICS
    申请人:Yu, Chongxi
    公开号:EP3357926A1
    公开(公告)日:2018-08-08
    The novel positively charged pro-drugs of beta-lactam antibiotics in the general 'Structure 4' were designed. The positively charged amino group of the pro-drug not only makes the drugs soluble in water, but also bonds to the negative charge on the phosphate head group of membranes. This bonding will disturb the membrane a little bit and may make some room for the lipophilic portion of the prodrug. The prodrugs can be used medicinally in treating beta-lactam antibiotics-treatable conditions in humans or animals. The prodrugs can be administered transdermally for any kind of medical treatments. Controlled transdermal administration systems of the prodrug enables beta-lactam antibiotics to reach constantly optimal therapeutic blood levels to increase effectiveness and reduce the side effects of beta-lactam antibiotics.
    我们设计出了一般 "结构 4 "中的新型带正电荷的β-内酰胺类抗生素原药。原药带正电荷的基不仅能使药物溶于,还能与膜上磷酸头基的负电荷结合。这种结合会稍微扰乱膜,并为原药的亲脂部分腾出一些空间。原药可用于治疗人类或动物体内可通过β-内酰胺类抗生素治疗的疾病。原药可以透皮给药,用于任何类型的医疗。原药的可控透皮给药系统可使β-内酰胺类抗生素不断达到最佳治疗血药浓度,从而提高疗效并减少β-内酰胺类抗生素的副作用。
  • Method for manufacturing stabilized polyacetal resin
    申请人:Polyplastics Co., Ltd.
    公开号:EP1867667B1
    公开(公告)日:2012-10-31
  • TRITERPENE QUATERNARY SALTS AS BIOLOGICALLY ACTIVE SURFACTANTS
    申请人:Krasutsky A. Pavel
    公开号:US20070088009A1
    公开(公告)日:2007-04-19
    The invention provides novel compounds that are quaternary amine derivatives of betulin and other triterpenes. The compounds have antibacterial, antifungal, and surfactant properties.
查看更多

同类化合物

阿地溴铵中间体 阿地溴铵 阿地溴胺杂质10 螺[1-氮杂双环[2.2.2]辛烷-3,2’-环氧乙烷] 盐酸盐 螺[1-氮杂双环[2.2.2]辛烷-3,2'-环氧乙烷] 苯环喹溴铵 羟甲基-7-氨基头孢烷酸 羟奎溴铵 索非那新杂质K 盐酸戊乙奎醚 沙可美林 帕洛诺司琼杂质23 奎宁环盐酸盐 奎宁环-4-基甲胺二盐酸盐 奎宁环-3-醇 盐酸盐 奎宁环-3-醇 奎宁环-3-硫醇 奎宁环-3-甲腈 奎宁环-2-酮肟 奎宁环-2-胺 奎宁环 化合物IBIGLUSTAT 化合物 T30247 克利溴铵杂质A 二盐酸(+)-N-(1(S)-苯基乙基)-1-氮杂二环[2.2.2]辛烷-3(R)-胺 二环[3.1.0]己烷-2,6-二羧酸,2-氨基-3-氟-,(1R,2R,3R,5S,6R)-rel- 乙酰克里定 a-(羟基甲基)-苯乙酸1-氮杂双环[2.2.2]辛-3-基酯 [(2S,5R)-5-乙烯基-1-氮杂双环[2.2.2]辛-2-基]甲醇 [(2E)-2-(1-铵双环[2.2.2]辛烷-3-亚基)乙基]2-环戊基-2-羟基-2-苯基乙酸酯氯化物 S-3-氨基奎宁环胺盐酸盐 S-3-氨基奎宁环二盐酸盐 R-3-氨基奎宁环二盐酸盐 O-吡喃鼠李糖基-(1-3)-O-吡喃木糖基-(1-2)-O-吡喃鼠李糖基-(1-4)-O-吡喃葡萄糖基-(1-1)-2-N-二十四烷酰(神经)鞘氨醇 N-苄基-1-氮杂双环[2.2.2]-3-辛胺 N-羟基奎宁环-3-羧酰胺 N-甲基醋克利定碘化物 N-甲基-1-氮杂二环[2.2.2]辛烷-3-胺 8-(1-甲基吡咯烷-2-基)-1-氮杂双环[2.2.2]辛烷 7-甲基-1-氮杂双环[2.2.2]辛烷-8-醇 5H-1,3-二噁唑并[4,5-c]吡咯-5-羧酸,4-[[[(1,1-二甲基乙基)二甲基甲硅烷基]氧代]甲基]四氢-2,2-二甲基-6-[4-(苯基甲氧基)-5-[[2-(三甲基甲硅烷基)乙氧基]甲基]-5H-吡咯并[3,2-d]嘧啶-7-基]-,1,1-二甲基乙基酯,(3aR,4R,6S,6aS)- 5-乙烯基-1-氮杂双环[2.2.2]辛烷-2-甲醛 4-碘-1-氮杂双环(2.2.2)辛烷 4-甲基-1-氮杂双环[2.2.2]辛烷 4-溴-1-氮杂双环[2.2.2]辛烷 4-氰奎宁环 4-氨甲基奎宁环 4-氟奎宁环-3-酮 4-奎宁环甲醛 4-乙基-1-氮杂双环[2.2.2]辛烷